JP2012520663A5 - - Google Patents

Download PDF

Info

Publication number
JP2012520663A5
JP2012520663A5 JP2012500143A JP2012500143A JP2012520663A5 JP 2012520663 A5 JP2012520663 A5 JP 2012520663A5 JP 2012500143 A JP2012500143 A JP 2012500143A JP 2012500143 A JP2012500143 A JP 2012500143A JP 2012520663 A5 JP2012520663 A5 JP 2012520663A5
Authority
JP
Japan
Prior art keywords
ctag1b
prame
ctag2
primer
maga3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012500143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012520663A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/001674 external-priority patent/WO2010105815A2/en
Publication of JP2012520663A publication Critical patent/JP2012520663A/ja
Publication of JP2012520663A5 publication Critical patent/JP2012520663A5/ja
Pending legal-status Critical Current

Links

JP2012500143A 2009-03-17 2010-03-17 遺伝子発現の改良された検出 Pending JP2012520663A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16093509P 2009-03-17 2009-03-17
US61/160,935 2009-03-17
PCT/EP2010/001674 WO2010105815A2 (en) 2009-03-17 2010-03-17 Improved detection of gene expression

Publications (2)

Publication Number Publication Date
JP2012520663A JP2012520663A (ja) 2012-09-10
JP2012520663A5 true JP2012520663A5 (https=) 2013-05-02

Family

ID=42224406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012500143A Pending JP2012520663A (ja) 2009-03-17 2010-03-17 遺伝子発現の改良された検出

Country Status (14)

Country Link
US (1) US20120039993A1 (https=)
EP (1) EP2408933A2 (https=)
JP (1) JP2012520663A (https=)
KR (1) KR20120002534A (https=)
CN (1) CN102575284A (https=)
AU (1) AU2010225125A1 (https=)
BR (1) BRPI1009873A2 (https=)
CA (1) CA2755734A1 (https=)
EA (1) EA021100B1 (https=)
IL (1) IL215182A0 (https=)
MX (1) MX2011009597A (https=)
SG (1) SG174877A1 (https=)
WO (1) WO2010105815A2 (https=)
ZA (1) ZA201107175B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481813A1 (en) * 2011-02-01 2012-08-01 Centro di Riferimento Oncologico - Istituto Nazionale Tumori - Aviano Markers of cutaneous melanoma and uses thereof
KR20130081515A (ko) 2012-01-09 2013-07-17 삼성전자주식회사 Led 패키지용 기판 및 led 패키지 제조방법
US9096905B2 (en) * 2012-02-23 2015-08-04 Medical Diagnostic Laboratories, Llc Detecting DNA methylation of BCL2, CDKN2A and NID2 genes to predict bladder cancer in humans
US11021752B2 (en) 2013-03-15 2021-06-01 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
US20180187267A1 (en) * 2017-01-05 2018-07-05 Michael J. Powell Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence
EP3164508B1 (en) 2014-07-02 2023-06-07 Myriad myPath, LLC Genes and gene signatures for diagnosis and treatment of melanoma
CN104611453B (zh) * 2015-02-28 2016-08-24 基因科技(上海)有限公司 诊断基因甲基化的探针组及其应用
WO2016208466A1 (ja) * 2015-06-22 2016-12-29 ウシオ電機株式会社 検出対象物質の検出方法
DE102016005947B3 (de) 2016-05-16 2017-06-08 Dimo Dietrich Verfahren zur Abschätzung der Prognose und zur Prädiktion des Ansprechens auf eine Immuntherapie von Patienten mit malignen Erkrankungen
US11685955B2 (en) 2016-05-16 2023-06-27 Dimo Dietrich Method for predicting response of patients with malignant diseases to immunotherapy
CN109400697B (zh) * 2017-08-17 2021-04-23 香雪生命科学技术(广东)有限公司 一种识别prame抗原短肽的tcr及其相关组合物
US11441182B2 (en) * 2018-08-08 2022-09-13 Virginia Commonwealth University Multiplexed and recyclable single-molecule sensors for quantitative analysis of nucleic-acid biomarkers
JP7216995B2 (ja) * 2018-12-05 2023-02-02 学校法人関西医科大学 胸腺癌バイオマーカー及び胸腺腫瘍の予後予測マーカー
CN110387421A (zh) * 2019-08-28 2019-10-29 深圳市新合生物医疗科技有限公司 用于肺癌检测的DNA甲基化qPCR试剂盒及使用方法
RU2760573C1 (ru) * 2021-01-20 2021-11-29 Общество с ограниченной ответственностью "Эс Джи" Набор олигонуклеотидных праймеров и флуоресцентно-меченых зондов для выявления эпигенетических маркеров рака шейки матки

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4437975A (en) 1977-07-20 1984-03-20 Mobil Oil Corporation Manufacture of lube base stock oil
WO1989001050A1 (en) 1987-07-31 1989-02-09 The Board Of Trustees Of The Leland Stanford Junior University Selective amplification of target polynucleotide sequences
US6723832B1 (en) 1996-10-03 2004-04-20 Ludwig Institute For Cancer Research Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
US6417165B1 (en) 1988-03-27 2002-07-09 Ludwig Institute For Cancer Research NY-ESO-1-peptide derivatives, and uses thereof
US5804381A (en) 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
US6252052B1 (en) 1996-10-03 2001-06-26 Cornell Research Foundation, Inc Antibodies which bind to NY-ESO-1 cancer associated proteins, and hybridomas which produce these antibodies
CA2005589C (en) 1988-12-16 2001-02-06 Akzo Nobel Nv Self-sustained, sequence replication system
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
US5342774A (en) 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
CA2138997C (en) 1992-06-25 2003-06-03 Jean-Paul Prieels Vaccine composition containing adjuvants
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
EP1167379A3 (en) 1994-07-15 2004-09-08 University Of Iowa Research Foundation Immunomodulatory oligonucleotides
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US5698396A (en) 1995-06-07 1997-12-16 Ludwig Institute For Cancer Research Method for identifying auto-immunoreactive substances from a subject
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
WO1998010087A1 (en) 1996-09-06 1998-03-12 Trustees Of The University Of Pennsylvania Chimpanzee adenovirus vectors
US6251603B1 (en) 1996-10-03 2001-06-26 Ludwig Institute For Cancer Research Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6303347B1 (en) 1997-05-08 2001-10-16 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
DE19752759A1 (de) 1997-11-28 1999-07-01 Basf Coatings Ag Triboelektrisch aufladbare Pulverlacke
CZ298364B6 (cs) 1998-02-05 2007-09-05 Smithkline Beecham Biologicals S. A. Deriváty antigenu asociovaných s nádory z MAGE rodiny a sekvence nukleových kyselin kodující tyto deriváty, jejich použití pro prípravu fúzních proteinu a prostredku pro vakcinaci
US6140050A (en) 1998-06-26 2000-10-31 Ludwig Institute For Cancer Research Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
PT1104306E (pt) 1998-08-10 2006-05-31 Antigenics Inc Composicoes de cpg e adjuvantes de saponina e seus metodos
US6800730B1 (en) 1998-10-02 2004-10-05 Ludwig Institute For Cancer Research Isolated peptides which bind to MHC class II molecules, and uses thereof
PT1187629E (pt) 1999-04-19 2005-02-28 Glaxosmithkline Biolog Sa Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
US6605711B1 (en) 1999-11-15 2003-08-12 Ludwig Institute For Cancer Research NY-ESO-1 peptide derivatives, and uses thereof
US6689742B1 (en) 2000-02-25 2004-02-10 Chancellors, Masters And Scholars Of The University Of Oxford NY-ESO-1 peptide derivatives, and uses thereof
US6756044B1 (en) 2000-02-09 2004-06-29 Genvec, Inc. Antigenic complexes and methods
AU2002365366B2 (en) 2001-11-21 2007-05-10 The Trustees Of The University Of Pennsylvania Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
US20030134404A1 (en) 2001-11-26 2003-07-17 Lochrie Michael A. Methods for producing stocks of recombinant AAV virions
DE60234386D1 (de) 2002-02-04 2009-12-24 Corixa Corp Neue immuneffektor-verbindungen
WO2004067726A2 (en) 2003-01-29 2004-08-12 Keck Graduate Institute Isothermal reactions for the amplification of oligonucleotides
US20050026183A1 (en) * 2003-05-15 2005-02-03 Jian-Bing Fan Methods and compositions for diagnosing conditions associated with specific DNA methylation patterns
DE10329240A1 (de) * 2003-06-24 2005-01-20 Epigenomics Ag Verfahren zur Analyse des Cytosin-Methylierungsstatus von Cancer-Testis-Antigenen für eine individualisierte Immuntherapie
GB0409940D0 (en) 2004-05-04 2004-06-09 Glaxosmithkline Biolog Sa Vaccine
US20090005268A1 (en) * 2005-07-18 2009-01-01 Epigenomics Ag Compositions and Methods for Cancer Diagnostics Comprising Pan-Cancer Markers
PT2114993E (pt) 2007-01-15 2012-11-28 Glaxosmithkline Biolog Sa Vacina
ES2398492T3 (es) 2007-01-15 2013-03-19 Glaxosmithkline Biologicals Sa Proteínas de fusión que comprenden los antígenos de rechazo tumoral NY-ESO-1 y LAGE-1
US20120142546A1 (en) * 2007-12-10 2012-06-07 The Johns Hopkins University Hypomethylated genes in cancer
WO2009108917A2 (en) * 2008-02-29 2009-09-03 Oncomethylome Sciences, S.A. Markers for improved detection of breast cancer

Similar Documents

Publication Publication Date Title
JP2012520663A5 (https=)
US20230250437A1 (en) Oligonucleotide probes and uses thereof
JP2010538633A5 (https=)
JP6285472B2 (ja) 診断及び治療のための腫瘍関連マーカーの同定
CN101932723B (zh) 改进的对mage-a表达的检测
ES2664386T3 (es) Identificación de antígenos asociados a tumor para el diagnóstico y la terapia
AU2017271579B2 (en) Oligonucleotide probes and uses thereof
AU742753B2 (en) Primers and methods for the detection of disseminated tumor cells
JP2012520663A (ja) 遺伝子発現の改良された検出
JP2012005500A (ja) 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定
JP2008532477A5 (https=)
JP5932808B2 (ja) 標的核酸の検出方法
KR20190026769A (ko) 유전자 발현 프로파일을 사용하여 폐암을 진단하기 위한 조성물 및 방법
CA2470965C (en) System biology approach: high throughput screening (hts) platforms with multiple dimensions
JP2009540852A5 (https=)
JP2011515091A5 (https=)
JP2012100628A (ja) Eml4−alk融合遺伝子の高感度検出方法
CN102597269A (zh) 用于鉴定患者是否将是免疫治疗的反应者的方法
JP2017046628A5 (https=)
JP2003325192A5 (https=)
JP2014527411A (ja) 癌におけるprame遺伝子発現の検出
JP5705191B2 (ja) Mage−a3マーカーの特異的検出のためのプライマーおよびプローブを含む癌の検出および診断の方法
CA2592504A1 (en) Classification of cancer
JP2009540812A5 (https=)
JP5965398B2 (ja) 任意の種類の注目される核酸配列に結合するタンパク質を単離するための新規な方法